Alex Thurman

Directeur Financier/CFO chez GLAUKOS CORPORATION

Fortune : 5 M $ au 31/03/2025

55 ans

Health Technology

Consumer Services

Profil

Alex Thurman currently works at Glaukos Corp., as Chief Financial Officer & Senior Vice President from 2022 and Allergan UC, as Vice President-Finance from 2016.
Mr. Thurman received his undergraduate degree and graduate degree from Brigham Young University.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
GLAUKOS CORP 0,09 %	21/04/2025	50 636 ( 0,09 % )	5 M $	31/03/2025

Dernières actualités sur Alex Thurman

Glaukos Corporation, Q4 2024 Earnings Call, Feb 20, 2025	20/02
Glaukos Corporation Presents at Citi's 2024 Global Healthcare Conference, Dec-05-2024 09:30 AM	05/12
Glaukos Corporation, Q3 2024 Earnings Call, Nov 04, 2024	04/11
Glaukos Corporation Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-05-2024 12:20 PM	05/09/24
Glaukos Corporation, Q2 2024 Earnings Call, Jul 31, 2024	31/07/24

Postes actifs de Alex Thurman

Sociétés	Poste	Début
GLAUKOS CORPORATION	Directeur Financier/CFO	01/04/2022
ALLERGAN PLC	Directeur Financier/CFO	01/12/2016

Tous les postes actifs de Alex Thurman

Formation de Alex Thurman

Brigham Young University

Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Alex Thurman

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées	1
GLAUKOS CORPORATION	Health Technology

Entreprise privées	1
Allergan Ltd. (Ireland) Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland.	Health Technology

Entreprise privées